VAERS reports by lot

GSK Hepatitis A lot T9TL9: VAERS reports

48 VAERS reports list lot T9TL9 as a GSK Hepatitis A vaccine, received between 2023-08-01 and 2024-12-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological833%
Injection-site / Local reaction417%
Cardiac / Cardiovascular312%
Musculoskeletal312%
General / Systemic (non-local)312%
Gastrointestinal28%
Respiratory14%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan6
North Carolina5
Indiana3
Wisconsin3
Ohio3
New York3
Tennessee3
Virginia2
Washington2
Colorado2
California2
Georgia2

Reports by month received

2023-084
2023-101
2023-117
2023-124
2024-013
2024-023
2024-038
2024-043
2024-053
2024-062
2024-073
2024-092
2024-101
2024-112
2024-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.